A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this study is to evaluate the efficacy of ustekinumab in Chinese participants with active systemic lupus erythematosus (SLE) who have not adequately responded to one or more standard‐of‐care treatments.
Epistemonikos ID: 78b20532e0e108e69b8e7e33b4a2e3688aa2b872
First added on: May 22, 2024